Therapeutics of postpartum depression

@article{Thomson2017TherapeuticsOP,
  title={Therapeutics of postpartum depression},
  author={Michael Thomson and Verinder Sharma},
  journal={Expert Review of Neurotherapeutics},
  year={2017},
  volume={17},
  pages={495 - 507}
}
ABSTRACT Introduction: Postpartum depression is a prevalent disorder affecting many women of reproductive age. Despite increasing public awareness, it is frequently underdiagnosed and undertreated leading to significant maternal morbidity and adverse child outcomes. When identified, postpartum depression is usually treated as major depressive disorder. Many studies have identified the postpartum as a period of high risk for first presentations and relapses of bipolar disorder. Areas covered… Expand
Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence.
TLDR
The evidence for and against diagnostic distinction for PPD is reviewed with respect to epidemiology, etiology, and treatment and it is suggested that PPD may be distinct, whereas depression occurring in the later postpartum period may be more similar to major depressive disorder occurring outside of the perinatal period. Expand
Bipolar postpartum depression: An update and recommendations.
TLDR
In the postpartum period, bipolar PPD is common, can be differentiated from unipolar PPD, and needs to be identified promptly in order to expedite appropriate treatment. Expand
Between a rock-a-bye and a hard place: mood disorders during the peripartum period
TLDR
Treatment of mood disorders during pregnancy is complicated by the potential risks of fetal exposure to psychotropic medications, and the use of these medications during the postpartum period may result in infant medication exposure through breastmilk. Expand
Pharmacotherapeutic considerations for the treatment of posttraumatic stress disorder during and after pregnancy
TLDR
Clinical studies and consensus guidelines in the treatment of perinatal PTSD are needed given the high prevalence of the disorder and the significant risks associated with inadequate treatment. Expand
Advances in treatment for postpartum major depressive disorder
TLDR
Large, randomized, controlled trials of hormonal treatments in patients with PPD are warranted and treatment with mood stabilizers and/or antipsychotics in women with major depressive disorder, who meet the DSM-5 mixed features specifiers in the post-partum period, should be tested in controlled clinical trials. Expand
Weighing the Risks: the Management of Bipolar Disorder During Pregnancy
TLDR
Management decisions of bipolar disorder in pregnancy have been made difficult by inconsistencies in study outcomes, and there were many confounding factors in the studies of medication discontinuation relapse risk. Expand
Non-pharmacological interventions for postpartum depression
  • Yang Wang, H. Li, +7 authors T. Zhu
  • Medicine
  • Medicine
  • 2020
TLDR
This network meta-analysis aims to compare, rank and interpret existed non-pharmacological evidence for the effective treatment of women with PPD, and systematically provide suggests for physicians and patients. Expand
Recommendations of the Polish Psychiatric Association regarding the treatment of affective disorders in women of childbearing age. Part II: Bipolar disorder.
TLDR
The article presented the recommendations of the Polish Psychiatric Association regarding pharmacological treatment of women with bipolar disorder during pregnancy and postpartum period, and suggested that a hospitalization and antipsychotic treatment are needed. Expand
A Systematic Review of the Efficacy of Repetitive Transcranial Magnetic Stimulation Treatment for Women with Postpartum Depression
TLDR
The poor quality of the evidence available indicates that TMS for PPD is unable to be currently recommended, and the substantial evidence for TMS in the treatment of MDD and the differential response to antidepressant medication in PPD indicates that further research into T MS is warranted. Expand
Efficacy of rTMS in decreasing postnatal depression symptoms: A systematic review
TLDR
RTMS shows promising results, with clinically significant decreases in Edinburgh Postnatal Depression Scale (EPDS) scores at week 4 and an overall low risk of dropout, and questions remain on what the most beneficial stimulation parameters should be. Expand
...
1
2
...

References

SHOWING 1-10 OF 104 REFERENCES
Prevention of recurrent postpartum major depression.
TLDR
Prophylactic antidepressant treatment reduced the recurrence of postpartum major depression among women who had suffered a previous episode of post partum depression. Expand
Is Your Depressed Postpartum Patient Bipolar
TLDR
Misdiagnosis of postpartum depression is more likely in cases of subtle bipolarity—BD II and BD not otherwise specified—than in BD I because:3 • physicians often fail to ask post partum patients about hypomanic symptoms such as feelings of elation, being overly talkative, racing thoughts, and decreased need for sleep. Expand
Does Antidepressant Use Attenuate the Risk of a Major Depressive Episode in Pregnancy?
TLDR
Failure to use or discontinuation of antidepressants in pregnancy did not have a strong effect on the development of a major depressive episode, and women with 4 or more depressive episodes before pregnancy were at high risk of a new episode, independent of antidepressant use. Expand
Perinatal depression: prevalence, screening accuracy, and screening outcomes.
TLDR
Although many screening instruments have been developed or modified to detect major and minor depression in pregnant and newly delivered women, the evidence on their screening accuracy relative to a reference standard has yet to be systematically reviewed and assessed. Expand
Venlafaxine in the treatment of postpartum depression.
TLDR
Venlafaxine is effective in the treatment of postpartum major depression in women who met DSM-III-R criteria for major depressive disorder with onset within the first 3 months post partum. Expand
Sertraline in the treatment of women with postpartum major depression
No consensus has yet been reached as to whether or not postpartum depression (PPD) represents a distinct clinical entity. Despite the increasing evidence that gender differences may exist inExpand
Is Postpartum Depression a Distinct Disorder?
TLDR
The evidence and arguments for and against the recognition of PPD as a distinct disorder are reviewed and the etiopathogenic and diagnostic validity of P PD is discussed, including its utility and indications for further research are discussed. Expand
The relationship between postpartum psychosis and bipolar disorder: a review.
TLDR
A comprehensive review of the literature regarding the relationships between postpartum psychosis and bipolar affective disorder, the data regarding prophylactic treatment and acute management of postpartUM psychosis andipolar disorder in the puerperium, and critical areas for future research finds a link between post partum schizophrenia and bipolar disorder exists. Expand
Factors associated with onset timing, symptoms, and severity of depression identified in the postpartum period.
TLDR
A collective set of factors predicted the onset of depression identified in the postpartum for mothers distinguished by episodes of unipolar versus bipolar depression, which can inform clinical interventions. Expand
Postpartum depression: Etiology, treatment and consequences for maternal care
TLDR
The literature on postnatal depression in the mother and its effect on mother-infant interactions is reviewed and interventions during gestation and postpartum that may improve maternal symptoms and behavior and thus alter developmental outcome of the offspring are discussed. Expand
...
1
2
3
4
5
...